Early warning for pharma supply teams

Find the supplier risk that could delay your next batch.

RxTrialHub connects commercial supplier names to FDA facilities, watches Warning Letters, Form 483s, and OAI classifications, and shows your team where to act first—within 24 hours.

FEI-backed identityFDA-source citationsPrioritized action queue

Start with 5 suppliers free for 14 days.

Recent FDA Alerts
Updated daily
Warning Letters
OAI Inspections
483 Pending
Suppliers Mapped
Live FDA alert examples will appear here once data is available.

How it works

1

Map the real facility

Enter the supplier name you know. RxTrialHub resolves aliases and FDA establishment identifiers.

2

Catch regulatory risk early

See matched Warning Letters, OAI classifications, and Form 483 activity without searching FDA databases.

3

Protect the next batch

Prioritize suppliers, open the FDA evidence, and move the issue into review before it becomes a disruption.

Built around supplier identity mapping

The defensible layer is FEI-to-commercial-name mapping. A buyer can type Aurobindo and the system can check multiple FDA facility identifiers.

Granules India
Cipla
Aurobindo Pharma
Divi's Laboratories

Pricing to test

Start narrow, then expand coverage as your supplier list grows.

Free Trial

$014 days
  • 5 suppliers
  • Email alerts
  • FDA.gov source links
  • No credit card required
View plan

Starter

$49per month
  • 50 suppliers
  • Daily digest
  • Warning Letter and OAI alerts
  • Single workspace
View plan

Team

$199per month
  • 200 suppliers
  • Real-time alerts
  • 3 seats
  • Shared alert workflow
View plan

Enterprise

Contactcustom
  • Unlimited suppliers
  • API access
  • Custom integrations
  • Priority support
View plan

Get weekly FDA supplier alerts

Useful even before your full watchlist is configured.